Namida

• There are significant gaps in the current breast cancer standard of care, mammography. Additionally, late cancer detection significantly increases treatment costs.
• Half of women do not get annual mammograms.
• Women under 40 are not eligible for a covered mammogram.
• Half of women have dense breast tissue, for whom mammograms are not effective.

Namida has sold over 4,000 cancer screening tests across B2B and B2C markets, totaling over $500,000 in revenue.

• 
  Anoma Foundation annouces Namada Mainnet at Korea Blockchain Week following a $25M fundraise - Tech Startups

  Tech Startups - Tech News, Tech Trends & Startup Funding · Sep 6, 2023

  The non-profit blockchain technology company, The Anoma Foundation, has unveiled its roadmap for the Namada mainnet. Awa Sun Yin, one of the co-founders of Namada, shared the announcement today during the Korea Blockchain Week in Seoul. The news comes just a few months after Anonoma raised $25 million in Series C funding to bring the